While previous work demonstrated that methodologies developed by Regen and covered under its issued patent #9,091,696 are useful in stimulation of T cell activity, the current patent further modifies T cells to express molecules that act as a localized “danger signal” to the immune system. CAR T cells are T Cells (T lymphocytes ) which are genetically engineered to produce chimeric antigen receptors (CARs) on their surface. CARs are proteins that allow the T cells to recognize an antigen on Continue Reading targeted tumor cells. Remarkable clinical results have been obtained by numerous investigators utilizing CAR T cells in the treatment of leukemias and lymphomas. Unfortunately, results for solid tumors have been limited. This is thought to occur because solid tumors produce numerous immune-suppressive factors look at this site that coax the cells that surround the tumor to protect the tumor against the immune response. By utilizing NR2F6-silencing methods, Regen believes it has developed a new method of augmenting the cells that surround the tumor to allow for immune destruction of the tumor to occur. “When we look at other chronic diseases, it is important to note that effective treatment protocols always involve multifactorial attacks on the disease process. This is best illustrated in the case of HIV where only after the introduction of the “cocktail therapy” approach have significant extensions of lifespan been achieved,” said Harry Lander, Ph.D., President and Chief Scientific Officer of Regen BioPharma. “By activating the adaptive arm of the immune system, in the form of NR2F6-silenced T cells, we anticipate achieving synergistic effects in killing of solid tumors, something which has not been observed in previous CAR-T approaches.” Augmentation of CAR-T cells has previously been performed with cytokines such as IL-12, however, IL-12 is one signal out of many signals involved in alerting the immune system to “danger”.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/regen-biopharma-inc-files-utility-130000746.html
This list includes hospital name, type of hospital, number of beds, rankings, reputation with physicians, skill level of nursing staff and survival averages. Another area that is ripe for social networking, especially in building your own practice locally, is to have your own biog or web log. It is relatively easy to set up your own biog. Identify any hospitals of interest. If you are not seeking a sub-specialty, identify what other elements are most relevant to you such as gender and location. News & World Reports” list of Best Hospitals. How to Know What to Ask Your look at here Doctor About Chemotherapy How to Know What to Ask Your Doctor About Chemotherapy is the name given to the treatment of cancer with anticancer drugs. Usually, attaining a DDT or DMZ degree requires at least three or more years of undergraduate work and an additional four years of dental school. Most men tend to cut-off visiting a doctor until they reach their mid-40s to 50s. If you’re a new patient, you might point out a previous fee arrangement with another doctor and then provide payment statements showing that you paid your bills on time.
Davis; Charles B. and Paula M. McFadden, $200; Mr. W.G. Brackin Sr, $50; Helen Childers, $100; David H. Rembert, Jr. and Margaret R. Rembert, $100; Betty Y. Thompson, $100, in memory of Roger C.
For the original version including any supplementary images or video, visit http://www.thestate.com/news/local/article121635317.html
You may also be interested to read
- have a peek at this website
- continue reading this